(1)
First Experience in Switzerland in Phe508del Homozygous Cystic Fibrosis Patients With End-Stage Pulmonary Disease Enrolled in a Lumacaftor-Ivacaftor Therapy Trial – Preliminary Results. Swiss Med Wkly 2018, 148 (0708), w14593. https://doi.org/10.4414/smw.2018.14593.